Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 3686 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#3686, RRID:AB_2077850
- Product name
- p27 Kip1 (D69C12) XP® Rabbit mAb
- Antibody type
- Monoclonal
- Reactivity
- Human, Rat, Simian
- Host
- Rabbit
- Storage
- -20°C
Submitted references The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes.
A mechanism for synergy with combined mTOR and PI3 kinase inhibitors.
EGFR- and VEGF(R)-targeted small molecules show synergistic activity in colorectal cancer models refractory to combinations of monoclonal antibodies.
Noncytotoxic differentiation treatment of renal cell cancer.
Stein C, Riedl S, Rüthnick D, Nötzold RR, Bauer UM
Nucleic acids research 2012 Oct;40(19):9522-33
Nucleic acids research 2012 Oct;40(19):9522-33
A mechanism for synergy with combined mTOR and PI3 kinase inhibitors.
Yang S, Xiao X, Meng X, Leslie KK
PloS one 2011;6(10):e26343
PloS one 2011;6(10):e26343
EGFR- and VEGF(R)-targeted small molecules show synergistic activity in colorectal cancer models refractory to combinations of monoclonal antibodies.
Poindessous V, Ouaret D, El Ouadrani K, Battistella A, Mégalophonos VF, Kamsu-Kom N, Petitprez A, Escargueil AE, Boudou P, Dumont S, Cervera P, Fléjou JF, André T, Tournigand C, Chibaudel B, de Gramont A, Larsen AK
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Oct 15;17(20):6522-30
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Oct 15;17(20):6522-30
Noncytotoxic differentiation treatment of renal cell cancer.
Negrotto S, Hu Z, Alcazar O, Ng KP, Triozzi P, Lindner D, Rini B, Saunthararajah Y
Cancer research 2011 Feb 15;71(4):1431-41
Cancer research 2011 Feb 15;71(4):1431-41
No comments: Submit comment
No validations: Submit validation data